The final dividend of EUR 0.25 per A - share (EUR 0.10 per B - share) will be paid to shareholders ...Lord and John Shaw to our Board of Directors as we continue to drive SES towards its next phase of ...
01Net
-
4-4-2025
|
|
|
During this early R&D innovation phase, experts explore various modulation schemes, including PAM4, ...and transformative ways." The Keysight M8199B Arbitrary Waveform Generator and Keysight N1032A/B ...
01Net
-
2-4-2025
|
|
|
... Over 900 trials focused on viral infections such as COVID - 19, HIV/AIDS, hepatitis B, and RSV, ...biotech and small - to mid - sized pharmaceutical companies to guide drug development at every phase. ...
01Net
-
2-4-2025
|
|
|
...by fully converting Convertible Loan Notes and significantly restructuring the Preferred B equity. Construction of Project Dorothy 2 started in the third quarter of 2024, and the initial phase of ...
01Net
-
1-4-2025
|
|
|
...in combination with lenalidomide for adult patients with r/r diffuse large B - cell lymphoma (DLBCL) who are not eligible for Autologous Stem Cell Transplant. Based on a single arm, open label Phase ...
01Net
-
27-3-2025
|
|
|
"This round is about seizing the opportunities ahead for our next phase of growth, including ... Since its Series B in 2021, Mercury has taken significant steps toward its vision that banking should do ...
01Net
-
26-3-2025
|
|
|
...first in vivo clinical validation for ARCUS gene editing across two distinct programs including wholly owned PBGENE - HBV and partnered program ECUR - 506 - - Commenced Phase 1 ELIMINATE - B clinical ...
01Net
-
26-3-2025
|
|
|
|
Per di più, già alla tornata 7, viene richiesto un tyre phase update per ricevere tutti i dati ... Per Charles, invece, viene scelto il Plan B. Leclerc aveva chiesto se non fosse meglio cambiare ...
23-3-2025
|
|
|
...construction activity while seeking debt financing to fund the remaining construction of Phase I of ... Going Concern Audit Opinion Pursuant to Section 610(b) of the NYSE American Company Guide, the ...
01Net
-
21-3-2025
|
|
|
"We are excited to share new supportive preclinical data for our lead clinical program PBGENE - HBV, which is currently enrolling patients in the ELIMINATE - B Phase 1 study. These new data highlight ...
01Net
-
20-3-2025
|
|
|